Functional Role of Eosinophils in Gastrointestinal Inflammation

Immunology and Allergy Clinics of North America

Volumn 29, Issue 1, 2009, Pages 129-140

  Hogan, Simon P ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Eosinophil; Eosinophilic gastroenteritis; Esophagitis; Inflammatory bowel disease

Indexed keywords

CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; MAJOR BASIC PROTEIN;

CELL FUNCTION; COLON DISEASE; DEGRANULATION; DIGESTIVE SYSTEM INFLAMMATION; EOSINOPHIL; EOSINOPHILIC COLITIS; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROENTERITIS; EOSINOPHILIC GASTROINTESTINAL DISORDER; ESOPHAGUS DISEASE; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE DISEASE;

ANIMALS; CELL DEGRANULATION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; EOSINOPHILS; EXOCYTOSIS; GASTROINTESTINAL DISEASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, MUCOSAL; MICE; TOLL-LIKE RECEPTORS;

EID: 58149260506     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2008.10.004     Document Type: Review

References (94)

1. Rothenberg M.E., Mishra A., Brandt E.B., et al. Gastrointestinal eosinophils in health and disease. Adv Immunol 78 (2001) 291-328
2. Hogan S.P., Rothenberg M.E., Forbes E., et al. Chemokines in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep 4 1 (2004) 74-82
3. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113 1 (2004) 11-28
4. Hogan S.P., Foster P.S., and Rothenberg M.E. Experimental analysis of eosinophil-associated gastrointestinal diseases. Curr Opin Allergy Clin Immunol 2 (2002) 239-248
5. Rothenberg M.E., Mishra A., Brandt E.B., et al. Gastrointestinal eosinophils. Immunol Rev 179 (2001) 139-155
6. Moon A., and Kleinman R.E. Allergic gastroenteropathy in children. Ann Allergy Asthma Immunol 74 1 (1995) 5-12
7. Keshavarzian A., Saverymuttu S.H., Tai P.C., et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 88 4 (1985) 1041-1049
8. Sherman M.P., and Cox K.L. Neonatal eosinophilic colitis. J Pediatr 100 4 (1982) 587-589
9. Furuta G.T. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 26 4 (1998) 468-471
10. Fox V.L., Nurko S., and Furuta G.T. Eosinophilic esophagitis. Gastrointest Endosc 56 (2002) 260-270
11. Walsh R.E., and Gaginella T.S. The eosinophil in inflammatory bowel disease. Scand J Gastroenterol 26 (1991) 1217-1224
12. Winter H.S., Madara J.L., Stafford R.J., et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 83 4 (1982) 818-823
13. Brown L.F., Goldman H., and Antonioli D.A. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 8 12 (1984) 899-905
14. Rothenberg M.E. Eosinophilia. N Engl J Med 338 22 (1998) 1592-1600
15. Sampson H.A. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 103 5 Pt 1 (1999) 717-728
16. Furuta G.T., Ackerman S.J., and Wershil B.K. The role of the eosinophil in gastrointestinal diseases. Curr Opin Gastroenterol 11 (1995) 541-547
17. Gleich G.J., and Adolphson C.R. The eosinophilic leukocyte: structure and function. Adv Immunol 39 177 (1986) 177-253
18. Weller P.F. The immunobiology of eosinophils. N Engl J Med 324 (1991) 1110-1118
19. Kay A.B., Phipps S., and Robinson D.S. A role for eosinophils in airway remodelling in asthma. Trends Immunol 25 9 (2004) 477-482
20. Lacy P., and Moqbel R. Eosinophil cytokines. Chem Immunol 76 (2000) 134-155
21. Lacy P., and Moqbel R. Eokines: synthesis, storage and release from human eosinophils. Mem Inst Oswaldo Cruz 92 Suppl (1997) H125-H133
22. Moqbel R., and Lacy P. Eosinophil cytokines. In: Busse W.W., and Holgate S.T. (Eds). Inflammatory mechanisms in asthma vol. 117 (1998), Marcel Dekker, Inc., New York 227-246
23. Spry C.J.F. Eosinophils. A comprehensive review and guide to the scientific and medical literature (1988), Oxford Medical Publications, Oxford (UK)
24. Gauthier M.C., Racine C., Ferland C., et al. Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. Int J Biochem Cell Biol 35 12 (2003) 1667-1673
25. Ohno I., Ohtani H., Nitta Y., et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 16 3 (1997) 212-219
26. Okada S., Kita H., George T.J., et al. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17 4 (1997) 519-528
27. Schwingshackl A., Duszyk M., Brown N., et al. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-β. J Allergy Clin Immunol 104 5 (1999) 983-989
28. Wiehler S., Cuvelier S.L., Chakrabarti S., et al. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochem Biophys Res Commun 315 2 (2004) 463-470
29. Tai P.-C., hayes D.J., Clark J.B., et al. Toxic effects of eosinophil secretion products on isolated rat heart cells in vitro. Biochem J 204 (1982) 75-80
30. Venge P., Dahl R., Hallgren R., et al. Cationic proteins of human eosinophils and their role in the inflammatory reaction. In: Mahmoud A.A.F., and Austin K.F. (Eds). The eosinophil in health and disease (1980), Grune and Stratton, New York 1131-1142
31. Frigas E., Loegering D.A., and Gleich G.J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest 42 1 (1980) 35-43
32. Gleich G.J., Frigas E., Loegering D.A., et al. The cytotoxic properties of the eosinophil major basic protein. J Immunol 123 (1979) 2925
33. Young J.D., Peterson C.G., Venge P., et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 321 6070 (1986) 613-616
34. Slifman N.R., Loegering D.A., McKean D.J., et al. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137 9 (1986) 2913-2917
35. Gleich G.J., Loegering D.A., Bell M.P., et al. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 83 10 (1986) 3146-3150
36. Rosenberg H.F., and Domachowske J.B. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70 5 (2001) 691-698
37. Venge P., Bystrom J., Carlson M., et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 29 (1999) 1172-1186
38. Zheutlin L.M., Ackerman S.J., Gleich G.J., et al. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 133 4 (1984) 2180-2185
39. Piliponsky A.M., Pickholtz D., Gleich G.J., et al. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions. J Allergy Clin Immunol 107 6 (2001) 993-1000
40. Jacoby D.B., Costello R.M., and Fryer A.D. Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol 107 2 (2001) 211-218
41. Morgan R.K., Costello R.W., Durcan N., et al. Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival. Am J Respir Cell Mol Biol 28 (2005) 28
42. Agosti J.M., Altman L.C., Ayars G.H., et al. The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J Allergy Clin Immunol 79 3 (1987) 496-504
43. Wu W., Chen Y., and Hazen S.L. Eosinophil peroxidase, nitrates, protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 274 36 (1999) 25933-25944
44. MacPherson J.C., Comhair S.A., Erzurum S.C., et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 166 (2001) 5763-5772
45. Logan M.R., Odemuyiwa S.O., and Moqbel R. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin Immunol 111 5 (2003) 923-932
46. Dvorak A.M., Furitsu T., Letourneau L., et al. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am J Pathol 138 1 (1991) 69-82
47. Lacy P., Mahmudi-Azer S., Bablitz B., et al. Rapid mobilization of intracellularly stored RANTES in response to interferon-γ in human eosinophils. Blood 94 (1999) 23-32
48. Bandeira-Melo C., Gillard G., Ghiran I., et al. EliCell: a gel-phase dual antibody capture and detection assay to measure cytokine release from eosinophils. J Immunol Methods 244 1-2 (2000) 105-115
49. Giembycz M.A., and Lindsay M.A. Pharmacology of the eosinophil. Pharmacol Rev 51 2 (1999) 213-340
50. Hartnell A., Moqbel R., Walsh G.M., et al. Fc gamma and CD1 1/CD 1 8 receptor expression on normal density and low density human eosinophils. Immunology 69 2 (1990) 264-270
51. Hartnell A., Kay A.B., and Wardlaw A.J. IFN-γ induces expression of Fc γ RIII (CD16) on human eosinophils. J Immunol 148 5 (1992) 1471-1478
52. Kim J.T., Schimming A.W., and Kita H. Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils. J Immunol 162 7 (1999) 4253-4259
53. Kita H., Abu-Ghazaleh R.I., Gleich G.J., et al. Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J Immunol 146 8 (1991) 2712-2718
54. Cromwell O., Moqbel R., Fitzharris P., et al. Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes 82 4 (1988) 535-543
55. Cromwell O., Wardlaw A.J., Champion A., et al. IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils 145 11 (1990) 3862-3868
56. Monteiro R.C., Hostoffer R.W., Cooper M.D., et al. Definition of immunoglobulin-A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 92 (1993) 1681-1685
57. Abu Ghazaleh R., Fujisawa T., Mestecky J., et al. IgA-induced eosinophil degranulation. J Immunol 142 7 (1989) 2393-2400
58. Kita H., and Gleich G.J. Eosinophils and IgE receptors: a continuing controversy. Blood 89 10 (1997) 3497-3501
59. Walsh G.M., Hartnell A., Moqbel R., et al. Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells. Blood 76 1 (1990) 105-111
60. DiScipio R.G., Daffern P.J., Jagels M.A., et al. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162 2 (1999) 1127-1136
61. Daffern P.J., Pfiefer P.H., Ember J.A., et al. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181 (1995) 2119-2127
62. Fischer E., Capron M., Prin L., et al. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3 97 2 (1986) 297-306
63. Koenderman L., Kuijpers T.W., Blom M., et al. Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor. J Allergy Clin Immunol 87 5 (1991) 947-954
64. Nagase H., Okugawa S., Ota Y., et al. Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 171 8 (2003) 3977-3982
65. Plotz S.G., Lentschat A., Behrendt H., et al. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97 1 (2001) 235-241
66. Sabroe I., Jones E.C., Usher L.R., et al. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 168 9 (2002) 4701-4710
67. Ahmad M., Soetikno R.M., and Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 30 3 (2000) 242-244
68. Orenstein S.R., Shalaby T.M., Di Lorenzo C., et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 95 (2000) 1422-1430
69. Walsh S.V., Antonioli D.A., Goldman H., et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 23 4 (1999) 390-396
70. Fox V.L., Nurko S., Teitelbaum J.E., et al. High-resolution EUS in children with eosinophilic "allergic" esophagitis. Gastrointest Endosc 57 1 (2003) 30-36
71. Kelly K.J. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr 30 Suppl (2000) S28-S35
72. Talley N.J., Shorter R.G., Phillips S.F., et al. Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 31 1 (1990) 54-58
73. Hogan S.P., Mishra A., Brandt E.B., et al. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2 4 (2001) 353-360
74. Dvorak A.M., Onderdonk A.B., McLeod R.S., et al. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol 102 1 (1993) 33-45
75. Schappi M.G., Smith V.V., Milla P.J., et al. Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut 52 (2003) 752-755
76. Hendrickson B.A., Gokhale R., and Cho J.H. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15 1 (2002) 79-94
77. Carvalho A.T., Elia C.C., de Souza H.S., et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 36 2 (2003) 120-125
78. Jeziorska M., Haboubi N., Schofield P., et al. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 194 4 (2001) 484-492
79. Desreumaux P., Nutten S., and Colombel J.F. Activated eosinophils in inflammatory bowel disease: do they matter?. Am J Gastroenterol 94 12 (1999) 3396-3398
80. Forbes E., Murase T., Yang M., et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol 172 (2004) 5664-5675
81. Kruidenier L., and Verspaget H.W. Oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous?. Aliment Pharmacol Ther 16 (2002) 1997-2015
82. Saleh D., Ernst P., Lim S., et al. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. Faseb J 12 11 (1998) 929-937
83. Massaro A.F., Mehta S., Lilly C.M., et al. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 153 (1996) 1510-1514
84. Kimura H., Hokari R., Miura S., et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42 2 (1998) 180-187
85. Kruidenier L., Kuiper I., van Duijn W., et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201 (2003) 17-27
86. Furuta G.T., Nieuwenhuis E.E., Karhausen J., et al. Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 289 5 (2005) G890-G897
87. Laukoetter M.G., Nava P., and Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 14 3 (2008) 401-407
88. Lawrance I.C. Inflammation location, but not type, determines the increase in TGF-B1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 7 (2001) 16-26
89. Gelbmann C.M., Mestermann S., Gross V., et al. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 45 2 (1999) 210-217
90. Xu X., Rivkind A., Pikarsky A., et al. Mast cells and eosinophils have a potential profibrogenic role in Crohn disease. Scand J Gastroenterol 39 5 (2004) 440-447
91. Levi-Schaffer F., Garbuzenko E., Rubin A., et al. Human eosinophils regulate human lung-and skin-derived fibroblast properties in vitro: a role for transforming growth factor β (TGF-β) 96 (1999) 9660-9665
92. Lampinen M., Ronnblom A., Amin K., et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 54 12 (2005) 1714-1720
93. Schmid-Grendelmeier P., Altznauer F., Fischer B., et al. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol 169 (2002) 1021-1027
94. Ohkawara Y., Tamura G., Iwasaki T., et al. Activation and transforming growth factor-β production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol 23 (2000) 444-451